About Bioanalytical Systems (NASDAQ:BASI)
Bioanalytical Systems, Inc. provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It operates through Contract Research Services and Research Products segments. The Contract Research Services segment offers screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing services. It also provides in vivo sampling services for the continuous monitoring of chemical changes in life; preclinical and pathology services; product characterization, method development, and validation; bioanalytical testing to measure drug and metabolite concentrations in complex biological matrices; stability testing to establish and confirm product purity, potency, and shelf life; and climate-controlled archiving services for its customers' data and samples. The Research Products segment offers analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments; and Vetronics' products, such as instruments and related software to monitor and diagnose cardiac function, and measure other vital physiological parameters in cats and dogs in veterinary clinics. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.
Industry, Sector and Symbol
Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:BASI
CUSIPN/A
Phone765-463-4527
Debt
Debt-to-Equity Ratio0.55%
Current Ratio0.71%
Quick Ratio0.59%
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$24.24 million
Price / Sales0.56
Cash Flow$0.3148 per share
Price / Cash5.21
Book Value$0.90 per share
Price / Book1.82
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$880,000.00
Net Margins3.85%
Return on Equity11.53%
Return on Assets4.06%
Miscellaneous
Employees155
Outstanding Shares8,250,000
Bioanalytical Systems (NASDAQ:BASI) Frequently Asked Questions
What is Bioanalytical Systems' stock symbol?
Bioanalytical Systems trades on the NASDAQ under the ticker symbol "BASI."
How were Bioanalytical Systems' earnings last quarter?
Bioanalytical Systems, Inc. (NASDAQ:BASI) announced its earnings results on Wednesday, February, 14th. The company reported ($0.01) EPS for the quarter. The business had revenue of $5.38 million for the quarter. Bioanalytical Systems had a return on equity of 11.53% and a net margin of 3.85%. View Bioanalytical Systems' Earnings History.
Who are some of Bioanalytical Systems' key competitors?
Some companies that are related to Bioanalytical Systems include Interpace Diagnostics Gr (IDXG), Aradigm (ARDM), Neuralstem (CUR), Tonix Pharmaceuticals (TNXP), AIT Therapeutics (AITB), AEterna Zentaris (AEZS), Akers Biosciences (AKR), Akari Therapeutics (AKTX), Regenerx Biopharmaceuticals (RGRX), IntelliPharmaCeutics Intl (IPCI), Dynatronics (DYNT), Oncobiologics (ONS), DelMar Pharmaceuticals (DMPI), ContraVir Pharmaceuticals (CTRV), AmpliPhi Biosciences (APHB), EnteroMedics (RSLS), Cellectar Biosciences (CLRB) and Cesca Therapeutics (KOOL).
Who are Bioanalytical Systems' key executives?
Bioanalytical Systems' management team includes the folowing people:
- Mr. Philip A. Downing, Acting Principal Exec. Officer & Sr. VP of Preclinical Services (Age 48)
- Dr. James Sevall Bourdage, VP of Bioanalytical Operations (Age 66)
- Dr. Peter T. Kissinger, Founder, Chairman Emeritus and Scientific Advisor (Age 73)
- Ms. Jill C. Blumhoff, Principal Accounting Officer, CFO & VP of Fin. (Age 42)
- Ms. Erica Wasson, Director of HR
Has Bioanalytical Systems been receiving favorable news coverage?
Headlines about BASI stock have trended somewhat negative on Friday, Accern Sentiment reports. Accern identifies positive and negative media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Bioanalytical Systems earned a media sentiment score of -0.01 on Accern's scale. They also gave media stories about the company an impact score of 47.80 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
How do I buy shares of Bioanalytical Systems?
Shares of BASI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Bioanalytical Systems' stock price today?
One share of BASI stock can currently be purchased for approximately $1.64.
How big of a company is Bioanalytical Systems?
Bioanalytical Systems has a market capitalization of $13.36 million and generates $24.24 million in revenue each year. Bioanalytical Systems employs 155 workers across the globe.
How can I contact Bioanalytical Systems?
Bioanalytical Systems' mailing address is 2701 KENT AVENUE, WEST LAFAYETTE IN, 47906. The company can be reached via phone at 765-463-4527 or via email at [email protected]
MarketBeat Community Rating for Bioanalytical Systems (BASI)
MarketBeat's community ratings are surveys of what our community members think about Bioanalytical Systems and other stocks. Vote "Outperform" if you believe BASI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BASI will underperform the S&P 500 over the long term. You may vote once every thirty days.
Bioanalytical Systems (NASDAQ:BASI) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
(Data available from 4/20/2016 forward)
Bioanalytical Systems (NASDAQ:BASI) Earnings History and Estimates Chart
Bioanalytical Systems (NASDAQ BASI) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 2/14/2018 | Q1 2018 | | ($0.01) | | $5.38 million | View | N/A |  |
| 8/14/2017 | Q3 2017 | | $0.03 | | $5.84 million | View | N/A | |
| 5/15/2017 | Q2 2017 | | $0.05 | | $6.36 million | View | N/A | |
| 12/22/2016 | Q4 2016 | | ($0.25) | | $5.15 million | View | N/A | |
| 8/11/2016 | Q316 | | ($0.05) | $6.15 million | $5.05 million | View | Listen | |
| 5/12/2016 | Q216 | | ($0.03) | $5.73 million | $5.34 million | View | Listen | |
| 2/16/2016 | Q116 | | ($0.06) | $5.95 million | $4.90 million | View | Listen | |
| 12/17/2015 | Q415 | | ($0.09) | $6.42 million | $4.98 million | View | Listen | |
| 8/13/2015 | Q315 | | $0.16 | $6.03 million | $6.15 million | View | Listen | |
| 5/14/2015 | Q215 | | ($0.01) | $5.92 million | $5.73 million | View | Listen | |
| 2/12/2015 | Q115 | | $0.01 | $6.22 million | $5.85 million | View | N/A | |
| 12/22/2014 | Q414 | | ($0.02) | | $6.42 million | View | N/A | |
| 8/14/2014 | Q314 | | $0.02 | $5.60 million | $6.03 million | View | N/A | |
| 5/15/2014 | Q2 | | ($0.03) | $5.16 million | $5.91 million | View | Listen | |
| 2/13/2014 | Q114 | | $0.04 | $5.80 million | $6.22 million | View | N/A | |
| 12/24/2013 | Q4 13 | | $0.03 | $6.54 million | $5.51 million | View | N/A | |
| 10/18/2013 | Q313 | $0.01 | $0.07 | $5.65 million | $5.60 million | View | N/A | |
| 5/15/2013 | Q2 2013 | $0.01 | ($0.02) | $5.74 million | $5.16 million | View | Listen | |
| 2/14/2013 | Q1 2013 | ($0.03) | $0.02 | $6.65 million | $5.80 million | View | Listen | |
| 12/27/2012 | Q4 2012 | ($0.03) | ($0.10) | | | View | N/A | |
| 8/14/2012 | Q3 2012 | ($0.14) | ($0.01) | | | View | N/A | |
| 5/11/2012 | Q2 2012 | $0.07 | ($0.26) | | | View | N/A | |
| 2/10/2012 | Q1 2012 | $0.06 | ($0.21) | | | View | N/A | |
| 12/20/2011 | Q4 2011 | $0.04 | ($0.10) | | | View | N/A | |
| 8/9/2011 | Q3 2011 | | ($0.65) | | | View | N/A | |
| 5/12/2011 | Q2 2011 | | $0.10 | | | View | N/A | |
| 2/7/2011 | Q1 2011 | | $0.06 | | | View | N/A | |
| 12/22/2010 | Q4 2010 | | ($0.06) | | | View | N/A | |
| 8/13/2010 | Q3 2010 | | $0.06 | | | View | N/A | |
| 5/14/2010 | Q2 2010 | | ($0.25) | | | View | N/A | |
| 2/16/2010 | Q1 2010 | | ($0.30) | | | View | N/A | |
| 1/14/2010 | Q4 2009 | | ($0.29) | | | View | N/A | |
| 8/10/2009 | Q3 2009 | | ($0.07) | | | View | N/A | |
| 5/15/2009 | Q2 2009 | | ($0.37) | | | View | N/A | |
| 1/14/2009 | Q4 2008 | | ($0.19) | | | View | N/A | |
| 8/11/2008 | Q3 2008 | | $0.08 | | | View | N/A | |
| 5/12/2008 | Q2 2008 | | ($0.03) | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Bioanalytical Systems (NASDAQ:BASI) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Bioanalytical Systems (NASDAQ BASI) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 2.50%
Institutional Ownership Percentage: 10.62%
Bioanalytical Systems (NASDAQ BASI) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/16/2018 | Philip A Downing | VP | Buy | 5,000 | $1.46 | $7,300.00 | | |
| 9/8/2017 | R Matthew Neff | Director | Buy | 5,000 | $1.50 | $7,500.00 | 10,000 | |
| 8/18/2017 | R Matthew Neff | Director | Buy | 5,000 | $1.70 | $8,500.00 | 5,000 | |
| 5/27/2016 | Connie Leigh Dougherty | VP | Buy | 423 | $0.92 | $389.16 | 9,074 | |
| 5/23/2016 | Connie Leigh Dougherty | VP | Buy | 96 | $0.92 | $88.32 | 8,651 | |
| 5/19/2016 | Connie Leigh Dougherty | VP | Buy | 1,655 | $0.92 | $1,522.60 | 8,555 | |
| 2/29/2016 | Jacqueline M Lemke | CEO | Buy | 10,000 | $1.18 | $11,800.00 | 60,685 | |
| 9/14/2015 | Philip A Downing | VP | Buy | 3,000 | $1.73 | $5,190.00 | 7,000 | |
| 2/27/2015 | Jacqueline M Lemke | CEO | Buy | 10,000 | $2.04 | $20,400.00 | | |
| 6/13/2014 | John P Devine | VP | Sell | 3,130 | $2.64 | $8,263.20 | | |
| 8/17/2012 | David L Omachinski | Director | Buy | 10,000 | $1.26 | $12,600.00 | | |
| 8/17/2012 | Jacqueline M Lemke | CEO | Buy | 20,000 | $1.26 | $25,200.00 | | |
(Data available from 1/1/2013 forward)
Bioanalytical Systems (NASDAQ BASI) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | BASi and Phlebotics Form Strategic Alliance; Continuing a Commitment to Automated Blood Sampling
finance.yahoo.com - April 4 at 4:30 PM |
| Bolstering Preclinical PK/PD Operations: BASi Hires Karen L. Rogers, DVM, DACLAM, CPIA as Attending Veterinarian
finance.yahoo.com - March 27 at 5:28 PM |
| What Investors Should Know About Bioanalytical Systems Inc’s (NASDAQ:BASI) Financial Strength
finance.yahoo.com - March 8 at 7:04 PM |
| Why Bioanalytical Systems Inc’s (NASDAQ:BASI) CEO Salary Matters To You
finance.yahoo.com - February 15 at 7:52 AM |
| All You Need To Know About Bioanalytical Systems Inc’s (NASDAQ:BASI) Risks
finance.yahoo.com - February 12 at 3:32 PM |
| Bioanalytical Systems to Release First Quarter Fiscal 2018 Results on Tuesday, February 13, 2018
finance.yahoo.com - February 8 at 3:31 PM |
 | Bioanalytical Systems (BASI) Scheduled to Post Earnings on Monday
www.americanbankingnews.com - February 5 at 4:16 AM |
| Why Bioanalytical Systems Inc (NASDAQ:BASI) Delivered An Inferior ROE Compared To The Industry
finance.yahoo.com - January 24 at 6:22 AM |
| Is Bioanalytical Systems Inc (NASDAQ:BASI) A Buy At Its Current PE Ratio?
finance.yahoo.com - January 2 at 4:23 PM |
| Bioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q4, 2017 By the Numbers : December 26, 2017
finance.yahoo.com - December 26 at 12:00 PM |
| Bioanalytical Systems Inc (BASI) Files 10-K for the Fiscal Year Ended on September 30, 2017
finance.yahoo.com - December 22 at 5:29 PM |
| BASi Continues Profitability Improvement to Close Out Fiscal 2017
finance.yahoo.com - December 19 at 11:06 AM |
| Bioanalytical Systems to Release Fourth Quarter and Full Year Fiscal 2017 Results on Tuesday, December 19, 2017
finance.yahoo.com - December 15 at 4:03 PM |
| Bioanalytical Systems (BASI) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - December 13 at 1:28 AM |
| BASi Announces Enhanced Bioequivalence Capabilities
finance.yahoo.com - December 12 at 11:43 AM |
| What Investors Should Know About Bioanalytical Systems Inc’s (BASI) Financial Strength
finance.yahoo.com - November 21 at 4:53 PM |
| Steady Growth Spurs Plans for BASi Expansion of GLP Toxicology Facility in Indiana
finance.yahoo.com - November 14 at 1:35 AM |
| Gaining Momentum: BASi Adds Candace Rohde-Johnson as Director of in Vivo Products and Services
finance.yahoo.com - October 3 at 4:06 PM |
| Bioanalytical Systems Inc (BASI): Is Healthcare An Attractive Sector Play?
finance.yahoo.com - September 22 at 3:18 PM |
| BASi and JOANNEUM RESEARCH Enter Into Collaboration to Commercialize Open Flow Microperfusion Technology
finance.yahoo.com - September 6 at 4:15 PM |
| Featured Company News - Myriad Genetics' EndoPredict Receives Positive Coverage Decisions from Palmetto and Anthem
finance.yahoo.com - August 22 at 10:03 PM |
| Bioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q3, 2017 By the Numbers : August 16, 2017
finance.yahoo.com - August 16 at 4:58 PM |
| Bioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q3, 2017 By the Numbers : August 16, 2017
finance.yahoo.com - August 16 at 4:58 PM |
| Bioanalytical Systems, Inc. (BASI) Releases Earnings Results
www.americanbankingnews.com - August 15 at 9:41 AM |
| BASi Reports Continued Profitability Improvement in Third Quarter
finance.yahoo.com - August 14 at 4:44 PM |
| BASi Announces Election of R. Matthew Neff to the Board of Directors
finance.yahoo.com - August 3 at 5:46 PM |
| Bioanalytical Systems, Inc. (NASDAQ:BASI) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - August 2 at 7:20 AM |
| BASi Signs Reseller Agreement With LABEX of MA for Refurbished Culex(R) Automated Blood Sampling Systems
finance.yahoo.com - July 31 at 4:27 PM |
 | Bioanalytical Systems, Inc.: BASi Names Dr. Gregory C. Davis to Board of Directors
www.finanznachrichten.de - June 20 at 4:31 PM |
 | BRIEF-BASI reports Q2 earnings per share $0.05
www.reuters.com - May 17 at 12:06 PM |
| Q1 2017 Bioanalytical Systems Inc Earnings Release - Before Market Open
us.rd.yahoo.com - February 14 at 8:27 PM |
 | BASi Reports First Quarter Results
us.rd.yahoo.com - February 14 at 8:27 PM |
| BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh
biz.yahoo.com - January 17 at 4:32 PM |
| Q4 2016 Bioanalytical Systems Inc Earnings Release - Before Market Open
us.rd.yahoo.com - December 22 at 3:51 PM |
| BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
biz.yahoo.com - December 22 at 3:51 PM |
| Bioanalytical Systems Inc Earnings Call scheduled for 2:00 pm ET today
biz.yahoo.com - December 22 at 3:51 PM |
| Bioanalytical Systems Inc Earnings Call scheduled for 2:00 pm ET today
biz.yahoo.com - December 22 at 3:51 PM |
| BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or S
biz.yahoo.com - December 7 at 4:26 PM |
| BRIEF-Basi Q3 loss per share $0.05
www.reuters.com - August 12 at 12:20 PM |
| BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Regulation FD Disclosure
biz.yahoo.com - August 4 at 3:50 PM |
| BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure
biz.yahoo.com - July 22 at 3:12 PM |
| BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - July 6 at 1:19 PM |
| BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - July 6 at 1:19 PM |
| Q2 2016 Bioanalytical Systems Inc Earnings Release - Before Market Open
biz.yahoo.com - May 12 at 7:07 AM |
| BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex
biz.yahoo.com - May 4 at 1:16 PM |
| BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - March 16 at 3:52 PM |
Bioanalytical Systems (NASDAQ:BASI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Bioanalytical Systems (NASDAQ:BASI) Income Statement, Balance Sheet and Cash Flow Statement
Bioanalytical Systems (NASDAQ BASI) Stock Chart for Friday, April, 20, 2018
Loading chart…
